Ligand Pharmaceuticals
LGND
LGND
305 hedge funds and large institutions have $2.85B invested in Ligand Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 140 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
305
Holders Change
-24
Holders Change %
-7.29%
% of All Funds
6.63%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
29
Increased
91
Reduced
140
Closed
49
Calls
$53.4M
Puts
$83.9M
Net Calls
-$30.5M
Net Calls Change
+$29.8M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$27.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.4M |
| 4 |
Renaissance Technologies
New York
|
-$15.4M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$13.1M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
351
Bessemer Group
Woodbridge,
New Jersey
| – | -$2K | -24 | Closed |
|
|
WEC
352
Winslow Evans & Crocker
Boston,
Massachusetts
| – | -$2K | -16 | Closed |
|
|
AIC
353
Ameritas Investment Company
Lincoln,
Nebraska
| – | -$1K | -11 | Closed |
|
|
IAS
354
IMA Advisory Services
Denver,
Colorado
| – | -$1K | -10 | Closed |
|